Stryker (SYK) is a publicly traded Healthcare sector company. As of July 5, 2026, SYK trades at $326.54 with a market cap of $125.18B and a P/E ratio of 37.40. SYK moved +4.20% today. Year to date, SYK is -7.79%; over the trailing twelve months it is -16.66%. Its 52-week range spans $281.00 to $406.19. Analyst consensus is strong buy with an average price target of $388.25. Rallies surfaces SYK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for SYK shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $326.54 |
| Market Cap | $125.18B |
| P/E Ratio | 37.40 |
| EPS | $8.73 |
| Dividend Yield | 0.88% |
| 52-Week High | $406.19 |
| 52-Week Low | $281.00 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $25.27B |
| Net Income | $3.34B |
| Gross Margin | 63.84% |
21 analysts cover SYK: 0 strong buy, 17 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $388.25.